Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis: A Randomized Trial

[1]  S. Kahn,et al.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy , 2008, Canadian Medical Association Journal.

[2]  G. Mariani,et al.  Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. , 2008, Blood.

[3]  G. Raskob,et al.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[4]  J. Douketis,et al.  The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism , 2007, Annals of Internal Medicine.

[5]  P. Prandoni,et al.  D‐dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[6]  L. Hofmann,et al.  Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline , 2007, Annals of Internal Medicine.

[7]  Paolo Prandoni,et al.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.

[8]  A. Iorio,et al.  D-dimer testing to determine the duration of anticoagulation therapy. , 2006, The New England journal of medicine.

[9]  D. Milne,et al.  Post‐treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  L. Tamariz,et al.  Duration of vitamin K antagonist therapy for venous thromboembolism: A systematic review of the literature , 2006, American journal of hematology.

[11]  A. Nicolaides,et al.  Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence) , 2006 .

[12]  E. Minar,et al.  The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease , 2005, Journal of thrombosis and haemostasis : JTH.

[13]  D. Ost,et al.  Duration of anticoagulation following venous thromboembolism: a meta-analysis. , 2005, JAMA.

[14]  B. Cosmi,et al.  Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long‐term recurrence , 2005, Journal of thrombosis and haemostasis : JTH.

[15]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[16]  W. Ageno,et al.  Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism , 2003, Annals of Internal Medicine.

[17]  P. Ridker,et al.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[18]  M. Prins,et al.  Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism , 2002, Annals of Internal Medicine.

[19]  P. Prandoni,et al.  The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis , 2002, Thrombosis and Haemostasis.

[20]  L. Galli,et al.  Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. , 2002, Haematologica.

[21]  W. Ageno,et al.  Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. , 2001, The New England journal of medicine.

[22]  I. Durieu,et al.  Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis , 2001, Circulation.

[23]  P. Simioni.  The molecular genetics of familial venous thrombosis. , 1999, Bailliere's best practice & research. Clinical haematology.

[24]  J. Douketis,et al.  Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.

[25]  O. Linder,et al.  The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.

[26]  Olle Linder,et al.  A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .

[27]  P Prandoni,et al.  A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis , 1993, Circulation.